AIH
Income statement / Annual
Last year (2023), Aesthetic Medical International Holdings Group Limited's total revenue was $682.59 M,
an increase of 1.86% from the previous year.
In 2023, Aesthetic Medical International Holdings Group Limited's net income was -$37.43 M.
See Aesthetic Medical International Holdings Group Limited’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$682.59 M
|
$670.09 M
|
$645.59 M
|
$901.57 M
|
$869.05 M
|
$761.31 M
|
$697.40 M
|
$584.86 M
|
| Cost of Revenue |
$360.54 M |
$314.51 M |
$376.09 M |
$356.80 M |
$275.95 M |
$258.57 M |
$234.52 M |
$217.34 M |
| Gross Profit |
$322.05 M |
$355.59 M |
$269.50 M |
$544.78 M |
$593.10 M |
$502.74 M |
$462.87 M |
$367.52 M |
| Gross Profit Ratio |
0.47 |
0.53 |
0.42 |
0.6 |
0.68 |
0.66 |
0.66 |
0.63 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$138.61 M
|
$150.38 M
|
$206.97 M
|
$230.65 M
|
$196.33 M
|
$115.49 M
|
$92.84 M
|
$121.76 M
|
| Selling & Marketing
Expenses |
$232.25 M
|
$226.47 M
|
$404.68 M
|
$510.61 M
|
$413.07 M
|
$333.53 M
|
$300.36 M
|
$231.23 M
|
| Selling, General &
Administrative Expenses |
$370.86 M
|
$376.85 M
|
$611.65 M
|
$741.25 M
|
$609.40 M
|
$449.01 M
|
$393.20 M
|
$352.99 M
|
| Other Expenses |
$8.30 M |
-$51.43 M |
$1.83 M |
-$999,000.00 |
$195.41 M |
-$280.21 M |
-$115.72 M |
$50.73 M |
| Operating Expenses |
$370.86 M |
$376.85 M |
$611.65 M |
$741.25 M |
$609.40 M |
$449.01 M |
$393.20 M |
$352.99 M |
| Cost And Expenses |
$731.40 M |
$691.36 M |
$987.75 M |
$1.10 B |
$885.35 M |
$707.58 M |
$627.72 M |
$570.33 M |
| Interest Income |
$78,000.00 |
$155,000.00 |
$113,000.00 |
$1.19 M |
$388,000.00 |
$322,000.00 |
$868,000.00 |
$309,000.00 |
| Interest Expense |
$14.47 M |
$21.64 M |
$27.23 M |
$29.19 M |
$23.91 M |
$9.24 M |
$6.58 M |
$2.92 M |
| Depreciation &
Amortization |
$65.90 M
|
$61.49 M
|
$99.14 M
|
$106.41 M
|
$83.83 M
|
$32.14 M
|
$29.11 M
|
$38.73 M
|
| EBITDA |
$25.47 M
|
$9.67 M
|
-$240.99 M
|
-$90.93 M
|
$177.37 M
|
-$192.29 M
|
-$17.48 M
|
$91.91 M
|
| EBITDA Ratio |
0.04 |
-0.02 |
-0.37 |
-0.22 |
0.2 |
-0.25 |
-0.03 |
0.18 |
| Operating Income Ratio
|
-0.07
|
-0.11
|
-0.53
|
-0.34
|
0.11
|
-0.3
|
-0.07
|
0.11
|
| Total Other
Income/Expenses Net |
-$6.25 M
|
-$72.91 M
|
-$339.16 M
|
-$63.02 M
|
$168.66 M
|
-$287.70 M
|
-$122.85 M
|
$10.51 M
|
| Income Before Tax |
-$55.06 M |
-$94.17 M |
-$681.31 M |
-$259.49 M |
$152.36 M |
-$233.97 M |
-$53.17 M |
$64.24 M |
| Income Before Tax Ratio
|
-0.08
|
-0.14
|
-1.06
|
-0.29
|
0.18
|
-0.31
|
-0.08
|
0.11
|
| Income Tax Expense |
-$15.14 M |
-$18.07 M |
-$11.80 M |
-$12.59 M |
$14.04 M |
$18.51 M |
$19.26 M |
$13.71 M |
| Net Income |
-$37.43 M |
-$76.11 M |
-$669.52 M |
-$246.91 M |
$136.31 M |
-$255.24 M |
-$76.68 M |
$50.35 M |
| Net Income Ratio |
-0.05 |
-0.11 |
-1.04 |
-0.27 |
0.16 |
-0.34 |
-0.11 |
0.09 |
| EPS |
-0.85 |
-2.79 |
-30.45 |
-11.36 |
5.77 |
-4.45 |
-1.34 |
0.89 |
| EPS Diluted |
-0.85 |
-2.79 |
-30.45 |
-11.36 |
5.77 |
-4.45 |
-1.34 |
0.89 |
| Weighted Average Shares
Out |
$43.89 M
|
$27.30 M
|
$21.99 M
|
$21.74 M
|
$23.61 M
|
$57.40 M
|
$57.40 M
|
$56.66 M
|
| Weighted Average Shares
Out Diluted |
$43.89 M
|
$27.30 M
|
$21.99 M
|
$21.74 M
|
$23.61 M
|
$57.40 M
|
$57.40 M
|
$56.66 M
|
| Link |
|
|
|
|
|
|
|
|
